🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)
China flag China · Delayed Price · Currency is CNY
2.900
-0.070 (-2.36%)
Nov 20, 2026, 3:04 PM CST

SHE:300026 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
1,6961,5021,3061,5741,2061,316
Cash & Short-Term Investments
1,6961,5021,3061,5741,2061,316
Cash Growth
19.93%15.00%-17.00%30.46%-8.34%16.89%
Accounts Receivable
2,2942,5722,8252,8923,5463,694
Other Receivables
27.8333.6138.3450.0949.9459.23
Receivables
2,3222,6062,8642,9423,5963,753
Inventory
1,3091,3711,7491,9612,2141,305
Prepaid Expenses
-13.5512.513.2532.1116.77
Other Current Assets
270.19224.12217.18230.06336.93416.22
Total Current Assets
5,5975,7176,1496,7207,3856,806
Property, Plant & Equipment
2,8072,9533,1493,2423,3222,901
Long-Term Investments
172.74178.84235.58247.62244.03272.82
Goodwill
629.39635.6675.2692.54716.05716.05
Other Intangible Assets
239.87267.14298.45331.11352.73313.68
Long-Term Accounts Receivable
65.2126.3946.3794.1115.01
Long-Term Deferred Tax Assets
234.02223.41222.17129.29140.56108.16
Long-Term Deferred Charges
388.36393.54386.75402.6327.29311.53
Other Long-Term Assets
27.5918.0222.7723.1477.6862.51
Total Assets
10,10210,39211,16511,83512,66011,607

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Accounts Payable
421.17449.97678.15713.45884.77605
Accrued Expenses
9.24268.52299.23184.08444.37519.36
Short-Term Debt
29.6814.8516.2423.18231.47293.79
Current Portion of Long-Term Debt
109.26116.65150.25167.67380.77100.02
Current Portion of Leases
-36.7545.2525.8855.0745.86
Current Income Taxes Payable
47.6810.2719.420.619.8215.12
Current Unearned Revenue
59.8552.0363.9776.27208.03137.56
Other Current Liabilities
447.27332.6348.67353.7463.6341.56
Total Current Liabilities
1,1241,2821,6211,5652,6782,058
Long-Term Debt
132.11260.59529.171,2571,3451,458
Long-Term Leases
77.12102.25111.1659.4278.1267.07
Long-Term Unearned Revenue
57.5562.0365.5662.5662.0467.55
Long-Term Deferred Tax Liabilities
24.0931.2839.5223.233.813.95
Total Liabilities
1,4151,7382,3672,9674,1973,655

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Common Stock
3,0043,0043,0043,0043,0043,004
Additional Paid-In Capital
589.89589.89589.89589.49589.49589.49
Retained Earnings
5,0294,9715,0435,1124,6954,199
Comprehensive Income & Other
-56.64-48.796.834.750.86-19.98
Total Common Equity
8,5678,5178,6448,7108,2907,773
Minority Interest
120.15137.68154.66157.7172.87179.49
Shareholders' Equity
8,6878,6548,7998,8688,4637,952
Total Liabilities & Equity
10,10210,39211,16511,83512,66011,607

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Total Debt
348.17531.1852.071,5332,0911,965
Net Cash (Debt)
1,348971.06454.1240.24-884.45-648.87
Net Cash Growth
76.44%113.83%1028.45%---
Net Cash Per Share
0.660.530.210.01-0.30-0.22
Filing Date Shares Outstanding
3,0043,0043,0043,0043,0043,004
Total Common Shares Outstanding
3,0043,0043,0043,0043,0043,004
Working Capital
4,4734,4354,5285,1554,7074,748
Book Value Per Share
2.852.832.882.902.762.59
Tangible Book Value
7,6987,6147,6707,6867,2216,743
Tangible Book Value Per Share
2.562.532.552.562.402.24
Buildings
-2,0001,9861,9881,7301,651
Machinery
-2,5522,5442,5142,1551,852
Construction In Progress
-130.89104.1954.11461.01232.93